Search Ontology:
ChEBI
EC 2.7.11.26 (tau-protein kinase) inhibitor
- Term ID
- CHEBI:91092
- Synonyms
-
- [tau-protein] kinase inhibitor
- [tau-protein] kinase inhibitors
- ATP:[tau-protein] O-phosphotransferase inhibitor
- ATP:[tau-protein] O-phosphotransferase inhibitors
- ATP:tau-protein O-phosphotransferase inhibitor
- ATP:tau-protein O-phosphotransferase inhibitors
- brain protein kinase PK40erk inhibitor
- brain protein kinase PK40erk inhibitors
- cdk5/p20 inhibitor
- cdk5/p20 inhibitors
- CDK5/p23 inhibitor
- CDK5/p23 inhibitors
- EC 2.7.11.26 (tau-protein kinase) inhibitors
- EC 2.7.11.26 inhibitor
- EC 2.7.11.26 inhibitors
- glycogen synthase kinase-3beta inhibitor
- glycogen synthase kinase-3beta inhibitors
- GSK inhibitor
- GSK inhibitors
- GSK-3 inhibitor
- GSK-3 inhibitors
- protein tau kinase inhibitor
- protein tau kinase inhibitors
- STK31 inhibitor
- STK31 inhibitors
- tau kinase inhibitor
- tau kinase inhibitors
- tau-protein kinase I inhibitor
- tau-protein kinase I inhibitors
- tau-protein kinase II inhibitor
- tau-protein kinase II inhibitors
- tau-tubulin inhibitor
- tau-tubulin inhibitors
- TPK I inhibitor
- TPK I inhibitors
- TPK II inhibitor
- TPK II inhibitors
- TPK inhibitor
- TPK inhibitors
- TTK inhibitor
- TTK inhibitors
- Definition
- An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of tau-protein kinase inhibitor (EC 2.7.11.26).
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- inverse has_role
Phenotype
Phenotype resulting from EC 2.7.11.26 (tau-protein kinase) inhibitor
Phenotype where environments contain EC 2.7.11.26 (tau-protein kinase) inhibitor
Phenotype modified by environments containing EC 2.7.11.26 (tau-protein kinase) inhibitor
Human Disease Model